CIC
HRMY icon

Cornercap Investment Counsel’s Harmony Biosciences HRMY Stock Holding History

Cornercap Investment Counsel’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-8,790
Closed -$302K – 290
2024
Q4 		$302K Hold
8,790
– – 0.1% 355
2024
Q3 		$352K Sell
8,790
-8,576
-49% -$301K 0.1% 324
2024
Q2 		$524K Sell
17,366
-149
-0.9% -$4.48K 0.09% 425
2024
Q1 		$588K Hold
17,515
– – 0.09% 367
2023
Q4 		$566K Buy
+17,515
New +$489K 0.09% 380
2022
Q3 		– Sell
-20,118
Closed -$981K – 589
2022
Q2 		$981K Sell
20,118
-4,584
-19% -$206K 0.17% 234
2022
Q1 		$1.2M Hold
24,702
– – 0.13% 207
2021
Q4 		$1.05M Sell
24,702
-5,399
-18% -$215K 0.15% 281
2021
Q3 		$1.15M Sell
30,101
-3,752
-11% -$121K 0.13% 256
2021
Q2 		$956K Buy
+33,853
New +$1.02M 0.11% 352

Other funds holding HRMY

VM
Valor Management Chicago, Illinois $181M AUM 6.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Cornercap Investment Counsel's HRMY Position: Q1 2025 in Review

Cornercap Investment Counsel sold out of Harmony Biosciences (HRMY) in Q1 2025, closing a stake of 8,790 shares — an estimated $302K sold.

Cornercap Investment Counsel first reported a position in HRMY in Q2 2021 and held it in 10 quarters. The position peaked at $1.2M in Q1 2022. 272 funds tracked by Wall St. Rank hold HRMY as of Q1 2025.

  • Cornercap Investment Counsel reported no remaining Harmony Biosciences position as of Q1 2025 after selling out during the quarter.
  • Cornercap Investment Counsel sold 8,790 Harmony Biosciences shares in Q1 2025, an estimated $302K.
  • Cornercap Investment Counsel first reported a position in Harmony Biosciences in Q2 2021 and held it in 10 quarters.
  • Cornercap Investment Counsel's Harmony Biosciences position peaked at $1.2M in Q1 2022.
  • 272 funds tracked by Wall St. Rank held Harmony Biosciences as of Q1 2025.

Based on Cornercap Investment Counsel's 13F filing for Q1 2025, filed 2 May 2025.